Pfizer CEO Albert Bourla and his vaccine partner BioNTech have said the companies expect phase 3 data by the end of October—and that an FDA application could soon follow. But more than 60 researchers and bioethicists urged the partners to wait for more safety data before submitting their shot for a green light, Bloomberg reports. The experts called on… Read More »
According to a study carried out by Lloyds Pharmacy 46% of Irish adults said they are planning on getting the flu vaccine this year. Research shows, 74 per cent of adults claim that the COVID-19 pandemic has made them more aware of the importance of being vaccinated against viruses. However, 46 per cent of adults… Read More »
Moderna’s coronavirus vaccine deal with the U.S., announced last week with a $ 1.525 billion price tag, would be worth far more if all options are exercised—and if the mRNA biotech meets an aggressive timeline for the shot’s arrival. The company stands to gain up to a whopping $ 8.125 billion, according to a Moderna… Read More »
A police officer patrols a deserted Red Square during the pandemic of the novel coronavirus (COVID-19). Valery Sharifulin Russia has rejected international criticism and skepticism toward its coronavirus vaccine, saying that it’s safe and that it works. Russia announced Tuesday that its vaccine had been approved by its health regulators, making it the first coronavirus… Read More »